An Opportunity to Transform Research on Rare Diseases in Europe 24/07/2026 Healthcare Rare diseases Personalized medicine Between 27 and 36 million people in the European Union live with one of the 6,000 to 8,000 known rare diseases. Partners - GENESIS Biomed
Illumina drives genomic education through G4US, a program that brings students and researc... 22/07/2026 Healthcare Personalized medicine Talento The Genomics for Universities Students (G4US) program is our commitment to supporting universities across Europe with... Partners - Illumina
#BIOSPAIN2026 | Encapsulation technologies: Driving the next generation of therapies 22/07/2026 Healthcare Personalized medicine International BioSpain The future of medicine will depend not only on discovering new drugs, but also on developing technologies capable of... AseBio
Immunological information: the new strategic infrastructure of personalised medicine 02/07/2026 Healthcare Personalized medicine Toni Vilaplana, CEO of Viva in Vitro Diagnostics. AseBio - VIVA IN VITRO
The debt biotechnology still owes Gregorio Marañón (and is now beginning to repay) 25/06/2026 Healthcare Access to innovation Personalized medicine In 1920, the Spanish physician and humanist Gregorio Marañón popularised and adopted the phrase coined by Hippocrates:... Partners - ProductLife Group
World ALS Day | “ALS research is currently going through a particularly promising moment” 21/06/2026 Healthcare Rare diseases Innovative drugs Personalized medicine We interview Alfonso de Egaña Barrenechea, CEO of Molefy Pharma, a company developing AP-2, an innovative molecule... AseBio - MOLEFY PHARMA
Research on the TDP-43 protein opens new therapeutic avenues for ALS 20/06/2026 Biotechnology is driving new strategies to combat ALS, including research on the TDP-43 protein, a key target involved... AseBio
BIOTECHX USA Boston United States Del 29/09/2026 to 30/09/2026 Healthcare Drug discovery Personalized medicine International
BCN HEALTH publishes a study evaluating the incidence and medical cost associated to intra... 03/06/2026 Healthcare Innovative drugs Personalized medicine Partners - BCN Health
The combination of biotechnology, biomarkers and clinical research is driving a new era in... 30/05/2026 SANOFI Biotechnology is redefining the approach to multiple sclerosis through new therapeutic tools, a more precise... AseBio - SANOFI
